Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Infect Control Hosp Epidemiol ; 40(5): 528-535, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30915929

RESUMEN

OBJECTIVE: To assess the safety of, and subsequent allergy documentation associated with, an antimicrobial stewardship intervention consisting of test-dose challenge procedures prompted by an electronic guideline for hospitalized patients with reported ß-lactam allergies. DESIGN: Retrospective cohort study. SETTING: Large healthcare system consisting of 2 academic and 3 community acute-care hospitals between April 2016 and December 2017. METHODS: We evaluated ß-lactam antibiotic test-dose outcomes, including adverse drug reactions (ADRs), hypersensitivity reactions (HSRs), and electronic health record (EHR) allergy record updates. HSR predictors were examined using a multivariable logistic regression model. Modification of the EHR allergy record after test doses considered relevant allergy entries added, deleted, and/or specified. RESULTS: We identified 1,046 test-doses: 809 (77%) to cephalosporins, 148 (14%) to penicillins, and 89 (9%) to carbapenems. Overall, 78 patients (7.5%; 95% confidence interval [CI], 5.9%-9.2%) had signs or symptoms of an ADR, and 40 (3.8%; 95% CI, 2.8%-5.2%) had confirmed HSRs. Most HSRs occurred at the second (ie, full-dose) step (68%) and required no treatment beyond drug discontinuation (58%); 3 HSR patients were treated with intramuscular epinephrine. Reported cephalosporin allergy history was associated with an increased odds of HSR (odds ratio [OR], 2.96; 95% CI, 1.34-6.58). Allergies were updated for 474 patients (45%), with records specified (82%), deleted (16%), and added (8%). CONCLUSION: This antimicrobial stewardship intervention using ß-lactam test-dose procedures was safe. Overall, 3.8% of patients with ß-lactam allergy histories had an HSR; cephalosporin allergy histories conferred a 3-fold increased risk. Encouraging EHR documentation might improve this safe, effective, and practical acute-care antibiotic stewardship tool.


Asunto(s)
Antibacterianos/efectos adversos , Programas de Optimización del Uso de los Antimicrobianos/métodos , Hipersensibilidad a las Drogas/epidemiología , beta-Lactamas/administración & dosificación , beta-Lactamas/efectos adversos , Adulto , Anciano , Antibacterianos/administración & dosificación , Cefalosporinas/administración & dosificación , Cefalosporinas/efectos adversos , Sistemas de Apoyo a Decisiones Clínicas , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Femenino , Humanos , Pacientes Internos , Masculino , Persona de Mediana Edad , Penicilinas/administración & dosificación , Penicilinas/efectos adversos , Guías de Práctica Clínica como Asunto , Estudios Retrospectivos , Estados Unidos/epidemiología , Adulto Joven
2.
Jt Comm J Qual Patient Saf ; 45(4): 285-294, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30527394

RESUMEN

BACKGROUND: The most common infection acquired in US hospitals is Clostridium difficile, which can lead to protracted diarrhea, severe abdominal cramping, and infectious colitis and an attributable mortality of 6.5%. The mortality associated with C. difficile is of major clinical importance. The best strategy to prevent such infections is an open question. METHODS: A multiyear quality improvement initiative was performed in our community hospital to determine where hospitals should focus their resources to achieve sustainable reductions in hospital-acquired C. difficile infection (CDI). Quality improvement methodology was used to evaluate the impact of sequential interventions in environmental cleaning, infection prevention, and antibiotic stewardship over time. RESULTS: After four years, hospital-acquired CDI declined 55.5%, from 12.2 to 5.4 cases/10,000 patient-days (Poisson rate test, p = 0.002). High-risk antibiotic use declined 88.1%, from 63.7 to 7.6 days on treatment/1,000 patient-days (Student's t-test, p < 0.001). The highest-impact intervention was stewardship on diagnostics and high-risk antibiotics using home-grown decision support tools. CONCLUSION: Translating scientific evidence into clinical practice using quality improvement methods led to sustained reductions in C. difficile transmission and identified high-risk antibiotics and diagnostics as key leverage points.


Asunto(s)
Infecciones por Clostridium/prevención & control , Infección Hospitalaria/prevención & control , Hospitales Comunitarios/organización & administración , Mejoramiento de la Calidad/organización & administración , Centros Médicos Académicos , Programas de Optimización del Uso de los Antimicrobianos , Infecciones por Clostridium/mortalidad , Infección Hospitalaria/mortalidad , Sistemas de Apoyo a Decisiones Clínicas , Servicio de Limpieza en Hospital , Humanos , Massachusetts
3.
J Allergy Clin Immunol Pract ; 5(3): 616-625.e7, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28483315

RESUMEN

Addressing inaccurate penicillin allergies is encouraged as part of antibiotic stewardship in the inpatient setting. However, implementing interventions targeted at the 10% to 15% of inpatients reporting a previous penicillin allergy can pose substantial logistic challenges. We implemented a computerized guideline for patients with reported beta-lactam allergy at 5 hospitals within a single health care system in the Boston area. In this article, we describe our implementation roadmap, including both successes achieved and challenges faced. We explain key implementation steps, including assembling a team, stakeholder engagement, developing or selecting an approach, spreading the change, establishing measures, and measuring impact. The objective was to detail the lessons learned while empowering others to be part of this important, multidisciplinary work to improve the care of patients with reported beta-lactam allergies.


Asunto(s)
Hipersensibilidad a las Drogas/diagnóstico , beta-Lactamas/efectos adversos , Boston , Humanos , Pacientes Internos , Guías de Práctica Clínica como Asunto , Pruebas Cutáneas , beta-Lactamas/uso terapéutico
4.
J Am Med Inform Assoc ; 24(5): 981-985, 2017 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-28371928

RESUMEN

Faced with national requirements to promote antimicrobial stewardship and reduce drug-resistant infections, community hospitals are challenged to make the best use of existing resources. Eighteen months after building antibiotic decision support into our electronic order platform, high-risk antibiotic use decreased by 83% (P < .001) at our community hospital. Hospital-acquired Clostridium difficile infections declined 24% (P = .07).


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones por Clostridium/prevención & control , Infección Hospitalaria/prevención & control , Quimioterapia Asistida por Computador , Utilización de Medicamentos/normas , Revisión de la Utilización de Medicamentos , Hospitales Comunitarios , Humanos , Prescripción Inadecuada , Massachusetts , Pautas de la Práctica en Medicina/estadística & datos numéricos , Mejoramiento de la Calidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...